Worldwide Distribution of Echinococcus granulosus sensu lato
E. granulosus sensu lato has a worldwide distribution, with the highest prevalence documented in Eastern Europe, the Middle East, North Africa, western China, central Asia, the Mediterranean region, eastern Africa, and parts of South America. 1
Global Distribution Pattern
The parasite is found on all continents except Antarctica 2. According to the most recent 2025 UK guidelines, E. granulosus presents worldwide, with cases in the UK most commonly occurring in migrants from Eastern Europe, Middle East, and North Africa 1.
Regional Prevalence Patterns
High Prevalence Regions
The areas with documented high disease burden include:
Asia: Western China and central Asia show particularly high prevalence 3. Recent systematic reviews confirm E. granulosus sensu stricto (G1-G3) is the most widely distributed genotype across five major continents 4
Middle East and Mediterranean: These regions consistently demonstrate elevated infection rates, with major space-time clusters identified in East/Central Asia and the Middle East 5
Eastern Europe: This region shows significant prevalence, particularly in countries like Russia, Kazakhstan, Kyrgyzstan, and Uzbekistan 6
Africa: Eastern Africa and North Africa are endemic areas, with documented prevalence in goats reaching 13.27% in some African regions 6
South America: Parts of South America show high prevalence, with meta-analysis revealing the highest pooled molecular prevalence of canine echinococcosis at 66.03% 7. Animal prevalence in goats ranges from 6.16%-10.85% 6
Ecological and Environmental Factors
Recent ecological niche modeling demonstrates that annual mean temperature (54.8% contribution) and elevation (23.5%) are the dominant predictors of E. granulosus distribution, with highest suitability under moderate temperature and precipitation conditions 5. The parasite shows a unimodal response to climatic gradients, explaining its geographic clustering in specific regions.
Clinical Context
The worldwide distribution creates significant public health challenges, as the disease poses a biological threat with increasing numbers of infected people globally 6. In the Russian Federation alone, the 2023 incidence was 494 cases (0.34 per 100,000 people) 6.
Important Caveat
While E. granulosus has worldwide distribution, low prevalence settings such as high-income countries often face challenges related to low disease awareness, leading to misdiagnosis and inappropriate treatments 8. This is particularly problematic as 134 out of 155 patients undergoing surgical treatment were initially misdiagnosed with either malignant or benign tumors 9.